All In Biotech

Drug Trial Radar · NCT00071331

EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan

Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure

Last checked: Nov 19, 2026Latest source record: May 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 3,600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,600

Actual

Start

Sep 2003

Primary completion

Jul 2006

Study completion Jul 2006

Sponsor

Sponsor type
Industry
First posted
Oct 21, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effectiveness of tolvaptan or placebo in adults with worsening congestive heart failure (CHF).

Conditions

  • Congestive Heart Failure

Interventions

  • TolvaptanDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

378 sites in 18 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • The Heart Center

    Huntsville, Alabama

  • The Heart Group

    Mobile, Alabama

  • Phoenix Memorial Hospital

    Gilbert, Arizona

  • Arizona Heart Institute

    Phoenix, Arizona

  • Saguaro Clinical Research

    Tucson, Arizona

  • Central Arkansas Veterans Healthcare Systems

    Little Rock, Arkansas

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Bakersfield Memorial Hospital

    Bakersfield, California

  • Central Cardiology Medical Center

    Bakersfield, California

  • Cardiology Associates

    Larkspur, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • LAC/USC Medical Center

    Los Angeles, California

  • VA Medical Center- W. Los Angeles

    Los Angeles, California

  • Mission Internal Medical Group

    Mission Viejo, California

  • ARI Clinical Trials

    Redondo Beach, California

  • San Diego Cardiac Center

    San Diego, California

  • Pacific Heart Institute

    Santa Monica, California

  • Cardiovascular Consultants Medical Group, Inc.

    Walnut Creek, California

  • Aurora Denver Cardiology Associates

    Denver, Colorado

  • University of Colorado

    Denver, Colorado

  • Heart and Vascular Clinic of North Colorado

    Fort Collins, Colorado

  • Bakus Resesarch

    Norwich, Connecticut

  • Christiana Care Health System

    Newark, Delaware

  • VA Medical Center

    Washington D.C., District of Columbia

  • Florida Cardiovascular Research

    Atlantis, Florida

  • Cardiology Associates of Fort Lauderdale

    Fort Lauderdale, Florida

  • Jacksonville Heart Center

    Jacksonville, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Jacksonville Heart Center

    Jacksonville Beach, Florida

  • Melbourne Internal Medicine Assoc.

    Melbourne, Florida

  • University of Miami/ Jackson Memorial Hospital

    Miami, Florida

  • Miami Research and Education Foundation

    Miami, Florida

  • Ocala Resarch Institute

    Ocala, Florida

  • Cardiology Research Associates

    Ormond Beach, Florida

  • Charlotte Heart Group Research Center

    Port Charlotte, Florida

  • Cardiovascular Center of Sarasota

    Sarasota, Florida

  • The Heart and Vascular Institute of Florida

    St. Petersburg, Florida

  • Cardiac Disease Specialists PC

    Atlanta, Georgia

  • Atlanta Heart and Vascular Research Group

    Atlanta, Georgia

Showing 40 of 378 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.